[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
Endpoints News @endpts on x 30.1K followers
Created: 2025-07-24 17:33:26 UTC
Novartis is paying $60M upfront to partner with Matchpoint on covalent inhibitors for inflammation. The deal could reach up to $1B with milestones and includes an option for exclusive rights.
XXXXX engagements
Related Topics $1b covalent $60m novartis $novnsw stocks healthcare